Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 25.54
-0.26 (-1.01%)
At close: Jan 22, 2026
BOM:531015 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 56.23 | 24.82 | 0.03 | 0 | 0 | 0.75 | Upgrade |
Cash & Short-Term Investments | 56.23 | 24.82 | 0.03 | 0 | 0 | 0.75 | Upgrade |
Cash Growth | 70182.50% | 99196.00% | 733.33% | - | -99.60% | 5485.27% | Upgrade |
Accounts Receivable | 34.71 | 9.53 | - | 0.36 | 0.36 | 0.36 | Upgrade |
Other Receivables | 2.55 | 0.27 | 0.13 | - | - | 1.04 | Upgrade |
Receivables | 37.26 | 9.79 | 0.13 | 0.36 | 0.36 | 1.4 | Upgrade |
Inventory | 15.29 | 0.58 | - | - | - | - | Upgrade |
Other Current Assets | 27.31 | 16.1 | - | 1.02 | 0.96 | 0.02 | Upgrade |
Total Current Assets | 136.08 | 51.29 | 0.16 | 1.38 | 1.33 | 2.17 | Upgrade |
Property, Plant & Equipment | 0.39 | 0.41 | 0.45 | 0.5 | 0.56 | 0.62 | Upgrade |
Other Intangible Assets | - | - | 0.21 | 0.23 | 0.26 | 0.28 | Upgrade |
Other Long-Term Assets | 0 | -0 | - | - | - | 0 | Upgrade |
Total Assets | 136.47 | 51.7 | 0.81 | 2.11 | 2.14 | 3.08 | Upgrade |
Accounts Payable | 18.84 | 6.29 | 1.03 | 3.29 | 4.71 | 4.65 | Upgrade |
Accrued Expenses | - | 0.31 | 1.21 | 1.99 | - | 0.49 | Upgrade |
Short-Term Debt | 31.07 | 0.5 | 3.52 | 3.52 | 3.49 | 23.29 | Upgrade |
Current Income Taxes Payable | - | - | 0.22 | - | - | - | Upgrade |
Other Current Liabilities | 0.78 | 0.48 | 1.29 | 0.42 | 3.3 | 2.47 | Upgrade |
Total Current Liabilities | 50.69 | 7.57 | 7.27 | 9.21 | 11.49 | 30.9 | Upgrade |
Long-Term Deferred Tax Liabilities | 0.01 | 0.01 | 0.05 | 0.05 | 0.05 | 0.04 | Upgrade |
Other Long-Term Liabilities | - | - | - | - | - | -0 | Upgrade |
Total Liabilities | 50.7 | 7.58 | 7.32 | 9.26 | 11.54 | 30.94 | Upgrade |
Common Stock | 80.08 | 52.39 | 52.39 | 52.39 | 52.39 | 52.39 | Upgrade |
Additional Paid-In Capital | - | - | - | - | 7.3 | 7.3 | Upgrade |
Retained Earnings | - | -58.99 | -58.89 | -59.53 | -69.09 | -87.56 | Upgrade |
Comprehensive Income & Other | 5.69 | 50.72 | -0 | - | - | - | Upgrade |
Shareholders' Equity | 85.77 | 44.12 | -6.5 | -7.15 | -9.4 | -27.86 | Upgrade |
Total Liabilities & Equity | 136.47 | 51.7 | 0.81 | 2.11 | 2.14 | 3.08 | Upgrade |
Total Debt | 31.07 | 0.5 | 3.52 | 3.52 | 3.49 | 23.29 | Upgrade |
Net Cash (Debt) | 25.16 | 24.33 | -3.5 | -3.52 | -3.49 | -22.54 | Upgrade |
Net Cash Per Share | 4.84 | 4.64 | -0.67 | -0.67 | -0.67 | -4.30 | Upgrade |
Filing Date Shares Outstanding | 4.88 | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | Upgrade |
Total Common Shares Outstanding | 4.88 | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | Upgrade |
Working Capital | 85.4 | 43.73 | -7.11 | -7.83 | -10.17 | -28.72 | Upgrade |
Book Value Per Share | 17.58 | 8.42 | -1.24 | -1.36 | -1.79 | -5.32 | Upgrade |
Tangible Book Value | 85.77 | 44.12 | -6.71 | -7.38 | -9.66 | -28.14 | Upgrade |
Tangible Book Value Per Share | 17.58 | 8.42 | -1.28 | -1.41 | -1.84 | -5.37 | Upgrade |
Machinery | - | - | - | - | 0.62 | 0.83 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.